Acquiring Company
Sobi
Acquired Company
CTI BioPharma
StockholmBiotechnologyHealth CareBiotechnologyHealth CareBiopharmaDescription
CTI BioPharma (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that it has entered into a definitive agreement under which Swedish Orphan Biovitrum AB (STO: SOBI) ("Sobi"), a global healthcare leader in hematology, immunology and specialty care, will acquire CTI for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of approximately $1.7 billion.
Other recent acquisitions in Biopharma and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Vivo Infusion Acquires Specialty Infusion Centers (June 20, 2023)
- Lilly To Acquire Dice Therapeutics To Advance Innovation In Immunology (June 20, 2023)
- Ironwood And Vectivbio Announce Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition Of Vectivbio (June 16, 2023)
- Veristat Acquires European Medical Writing Consultancy Scinopsis (June 12, 2023)
- Solmetex, Llc Acquires Impladent Ltd. (June 5, 2023)
- Abiogen Pharma Completes The Acquisition Of Effrx (May 29, 2023)
Who to call at Sobi, and when
When Sobi changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Sobi raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sobi, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sobi. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sobi makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired CTI BioPharma?
CTI BioPharma was acquired by Sobi, based in Stockholm. The deal was reported on May 10, 2023. Sobi® is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases. Sobi is privately held and operates in Biotechnology.
When did Sobi acquire CTI BioPharma?
Sobi's acquisition of CTI BioPharma was reported on May 10, 2023. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does CTI BioPharma do?
CTI BioPharma is a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.